Loading
NASDAQHealthcareMedical - Pharmaceuticals
Latest quote
$8.94
+$0.33 · +3.83%
Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.
Previous close
$8.94
+$0.33 · +3.83%
After-hours
$8.94
$0.00 · 0.00%
Oct 14, 6:31 PM ET
Regular session · ET · Market data may be delayed.
Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.
Day range
Current $8.94
52-week range
Current $8.94
Regular session · ET · Market data may be delayed.
Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.
Day range
Current $8.94
52-week range
Current $8.94
Third-party consensus; not a GoAI recommendation.
Average target
$32.00
257.94% upsideFunds reporting this stock among their holdings, ordered by reported position size.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
